Vincent Meunier

Stock Analyst at Morgan Stanley

(0.67)

# 3,055

Out of 4,496 analysts

5

Total ratings

33.33%

Success rate

-4.48%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVS Novartis AG	Upgrades: Equal-Weight	n/a	$106.13	-	3	Sep 25, 2023
	NVO Novo Nordisk	Initiates: Equal-Weight	n/a	$131.54	-	2	Dec 14, 2018

Novartis AG

Sep 25, 2023

Upgrades: Equal-Weight

Price Target: n/a

Current: $106.13

Upside: -

Novo Nordisk

Dec 14, 2018

Initiates: Equal-Weight

Price Target: n/a

Current: $131.54

Upside: -